ReviewDiabetology & metabolic syndrome2022

Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.

Qian-Long Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.